Cloning and characterization of bovine interleukin-32 beta isoform

Veterinary Immunology and Immunopathology

Volumn 137, Issue 1-2, 2010, Pages 166-171

  Jaekal, Jun ^a   Jhun, Hyunjhung ^a   Hong, Jaewoo ^a   Park, Seungyoung ^b   Lee, Joongbok ^b   Yoon, Doyoung ^b   Lee, Siyoung ^c   Her, Erk ^c   Yang, Young ^d   Rho, Gyujin ^e   Kim, Soohyun ^a  

^a Konkuk University   (South Korea)

^b Konkuk University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Sookmyung Women's University   (South Korea)

^e Gyeongsang National University   (South Korea)

Author keywords

Affinity chromatography; Cytokine; Inflammation; Peripheral blood mononuclear cells (PBMC); Recombinant protein

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1BETA; INTERLEUKIN 32; INTERLEUKIN 32 BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL STIMULATION; CONTROLLED STUDY; COW; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION;

BOS; BOS TAURUS; BOVINAE;

EID: 77955558958     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.04.019     Document Type: Article

References (27)

1. Bazan J.F., Timans J.C., Kastelein R.A. A newly defined interleukin-1?. Nature 1996, 379:591.
2. Choi J.D., Bae S.Y., Hong J.W., Azam T., Dinarello C.A., Her E., Choi W.S., Kim B.K., Lee C.K., Yoon D.Y., Kim S.J., Kim S.H. Identification of the most active interleukin-32 isoform. Immunology 2009, 126:535-542.
3. Csernok E., Holle J.U., Gross W.L. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. Clin. Exp. Rheumatol. 2008, 26:S112-S117.
4. Dahl C.A., Schall R.P., He H.L., Cairns J.S. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992, 148:597-603.
5. Dinarello C.A., Kim S.H. IL-32, a novel cytokine with a possible role in disease. Ann. Rheum. Dis. 2006, 65(Suppl. 3):iii61-iii64.
6. Goda C., Kanaji T., Kanaji S., Tanaka G., Arima K., Ohno S., Izuhara K. Involvement of IL-32 in activation-induced cell death in T cells. Int. Immunol. 2006, 18:233-240.
7. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., Su M.S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997, 275:206-209.
8. Joosten L.A., Netea M.G., Kim S.H., Yoon D.Y., Oppers-Walgreen B., Radstake T.R., Barrera P., van de Loo F.A., Dinarello C.A., van den Berg W.B. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3298-3303.
9. Kim S.H., Azam T., Yoon D.Y., Reznikov L.L., Novick D., Rubinstein M., Dinarello C.A. Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3304-3309.
10. Kim S.H., Han S.Y., Azam T., Yoon D.Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
11. Ko N.Y., Chang S.H., Lee J.H., Kim N.W., Kim Y.M., Choi W.S., Choi J.D., Bae S.Y., Hong J.W., Jaekal J., Azam T., Her E., Kim S.H. Unique expression of a small IL-32 protein in the Jurkat leukemic T cell line. Cytokine 2008, 42:121-127.
12. Kumar S., Hanning C.R., Brigham-Burke M.R., Rieman D.J., Lehr R., Khandekar S., Kirkpatrick R.B., Scott G.F., Lee J.C., Lynch F.J., Gao W., Gambotto A., Lotze M.T. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002, 18:61-71.
13. Li W., Yang F., Liu Y., Gong R., Liu L., Feng Y., Hu P., Sun W., Hao Q., Kang L., Wu J., Zhu Y. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur. J. Immunol. 2009, 39:1019-1024.
14. Meazza R., Verdiani S., Biassoni R., Coppolecchia M., Gaggero A., Orengo A.M., Colombo M.P., Azzarone B., Ferrini S. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 1996, 12:2187-2192.
15. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001, 12:53-72.
16. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., Abraham E., Kim J.M., Yoon D.Y., Dinarello C.A., Kim S.H. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16309-16314.
17. Netea M.G., Azam T., Lewis E.C., Joosten L.A., Wang M., Langenberg D., Meng X., Chan E.D., Yoon D.Y., Ottenhoff T., Kim S.H., Dinarello C.A. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 2006, 3:e277.
18. Netea M.G., Lewis E.C., Azam T., Joosten L.A., Jaekal J., Bae S.Y., Dinarello C.A., Kim S.H. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3515-3520.
19. Nishimura H., Washizu J., Nakamura N., Enomoto A., Yoshikai Y. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J. Immunol. 1998, 160:936-942.
20. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136.
21. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C.A., Kim S.H. Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3316-3321.
22. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces interferon-g. Nature 1995, 378:88-91.
23. Okamura H., Tsutsui H., Kashiwamura S.-I., Yoshimoto T., Nakanishi K. IL-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 1998, 70:281-312.
24. Pearson W.R., Lipman D.J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:2444-2448.
25. Pufe T., Petersen W., Tillmann B., Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum. 2001, 44:1082-1088.
26. Shioya M., Nishida A., Yagi Y., Ogawa A., Tsujikawa T., Kim-Mitsuyama S., Takayanagi A., Shimizu N., Fujiyama Y., Andoh A. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin. Exp. Immunol. 2007, 149:480-486.
27. Shoda H., Fujio K., Yamaguchi Y., Okamoto A., Sawada T., Kochi Y., Yamamoto K. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res. Ther. 2006, 8:R166.